SS
SNDX icon

Sunbelt Securities’s Syndax Pharmaceuticals SNDX Stock Holding History

Sunbelt Securities’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.07K Hold
260
– – ﹤0.01% 1624
2025
Q4 		$5.46K Buy
260
+30
+13% +$523 ﹤0.01% 1612
2025
Q3 		$3.54K Buy
+230
New +$3.01K ﹤0.01% 1716

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Sunbelt Securities's SNDX Position: Q1 2026 in Review

Sunbelt Securities held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 260 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Sunbelt Securities first reported a position in SNDX in Q3 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Sunbelt Securities held 260 shares of Syndax Pharmaceuticals worth $6.07K as of Q1 2026.
  • Sunbelt Securities left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1624 holding.
  • Sunbelt Securities first reported a position in Syndax Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.